Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for prevention of contrast-induced nephropathy
IRCT2014072318389N2Phase 2Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of allopurinol in contrast-induced nephropathy (CIN) and acute kidney failure (AKF), sponsored by Qom University of Medical Sciences. Primary endpoint: Incidence of contrast-induced nephropathy. Started Aug 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
contrast-induced nephropathy (CIN)acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT2014072318389N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014072318389N2.